With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

entrepreneurial operating system
The Framework Series Advantage: Scaling Smarter with the Entrepreneurial Operating System
January 30, 2025

Entrepreneurs often struggle with scaling their businesses while maintaining clarity and efficiency. The Entrepreneurial Operating System (EOS), introduced by Gino Wickman in Traction, has gained traction since 2020 for helping leadership teams streamline operations, boost accountability, and achieve sustainable growth. Research shows that businesses with structured operational frameworks outperform their peers in revenue growth…

Read More
Marketing AI adoption
Marketing AI Adoption in B2B Enterprises
January 30, 2025

Aby Varma, founder of Spark Novus, leads a discussion on how AI is reshaping marketing within large B2B enterprises. He speaks with Shonodeep Modak, CMO of Schneider Electric’s Energy Management Business, about their AI journey, operational challenges, and strategies for successful AI adoption in marketing. They highlight lessons learned, misconceptions, and the future of…

Read More
frameworks
The Framework Series Advantage: Actionable Frameworks Drive Business Success
January 29, 2025

Businesses often invest heavily in training programs and methodologies, only to see them underutilized or abandoned due to complexity. This challenge underscores the importance of adopting streamlined, actionable frameworks that drive real results. Research shows that many small businesses struggle due to ineffective strategies and a lack of practical implementation tools. How can organizations…

Read More
AI sales and marketing tools
AI Sales and Marketing Tools Are Changing the Game But Are They Helping?
January 29, 2025

Over the past decade, marketing has become increasingly data-driven, with AI sales and marketing tools promising deeper insights and improved decision-making. Businesses have invested heavily in AI and automation, believing that more data equates to better performance. However, this shift has also created unintended challenges. According to a study by Gartner, only 54% of…

Read More